Name: Retatrutide 5mg + Cagrilintide 5mg Blend

Synonyms: Quad-agonist metabolic stack; Triple GLP-1/GIP/GCGR + Amylin dual-system combo; Advanced obesity research peptide; Max efficacy metabolic peptide blend; Retatrutide/Cagrilintide mixed impurity; USP/EP/BP grade compound related Specification: Retatrutide 5mg + Cagrilintide 5mg per vial Core Synergy Mechanism: Retatrutide acts as triple receptor agonist (GLP-1/GIP/GCGR) to boost energy expenditure, inhibit hunger and accelerate fat breakdown; Cagrilintide simulates amylin pathway to delay gastric emptying, extend fullness and suppress compensatory rebound appetite. Four metabolic pathways work simultaneously, delivering stronger and longer-lasting metabolic regulation than single or dual peptide formulas. EINECS：200-001-8